Neurology Diagnostic And Monitoring Devices Market Report 2026

Neurology Diagnostic And Monitoring Devices Market Overview

• Neurology Diagnostic And Monitoring Devices market size has reached to $9.32 billion in 2025 • Expected to grow to $14.38 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Increasing Prevalence Of Neurodegenerative Diseases Is Driving The Growth Of The Neurology Diagnostic And Monitoring Devices Market • Market Trend: Advancements In Neurology Diagnostic And Monitoring Devices Enhanced Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neurology Diagnostic And Monitoring Devices Market?

Neurology diagnostic and monitoring devices are medical tools used to diagnose and monitor disorders of the nervous system, including the brain, spinal cord, and peripheral nerves. These devices assess neurological functions and help detect conditions such as epilepsy, stroke, Alzheimer's disease, and multiple sclerosis. The main device types of neurology diagnostic and monitoring devices are electroencephalogram (EEG) systems, magnetic resonance imaging (MRI) systems, computed tomography (CT) scanner, position emission tomography (PET) system, ultrasound imaging systems, and others. Electroencephalogram (EEG) systems refer to devices that measure and record electrical activity in the brain using electrodes placed on the scalp. These devices are used for various indications such as neurodegenerative diseases, epilepsy, stroke, and more. The end users include hospitals and surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories and imaging centers, and laboratories and academic institutes.

What Is The Neurology Diagnostic And Monitoring Devices Market Growth Forecast?

The neurology diagnostic and monitoring devices market size is expected to see strong growth in the next few years. It will grow to $14.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to demand for remote patient monitoring, expansion of neurology centers, increasing awareness of brain health, technological advancements in imaging, rising research investments. Major trends in the forecast period include increasing use of portable neurology devices, growing demand for early disease diagnosis, expansion of remote neurological monitoring, rising adoption of non-invasive diagnostic tools, growth in multimodal imaging approaches.

Global Neurology Diagnostic And Monitoring Devices Market Segmentation

1) By Device Type: Electroencephalogram (EEG) Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Scanner, Position Emission Tomography (PET) System, Ultrasound Imaging Systems, Other Device Types 2) By Indication: Neurodegenerative Disease, Epilepsy, Stroke, Other Indications 3) By End-User: Hospitals And Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories And Imaging Centers, Research Laboratories And Academic Institutes Subsegments: 1) By Electroencephalogram (EEG) Systems: Portable EEG Systems, Clinical EEG Systems, Wireless EEG Systems 2) By Magnetic Resonance Imaging (MRI) Systems: Closed MRI Systems, Open MRI Systems, Functional MRI (fMRI) Systems 3) By Computed Tomography (CT) Scanner: Standard CT Scanners, High-Definition CT Scanners, 3D CT Scanners 4) By Position Emission Tomography (PET) System: PET-CT Scanners, PET-MRI Scanners 5) By Ultrasound Imaging Systems: Diagnostic Ultrasound Systems, 3D And 4D Ultrasound Systems, Portable Ultrasound Systems 6) By Other Device Types: Nerve Conduction Study (NCS) Devices, Evoked Potential (EP) Systems, Brain Implants And Neurostimulators

What Is The Driver Of The Neurology Diagnostic And Monitoring Devices Market?

The increasing prevalence of neurodegenerative diseases is expected to propel the growth of the neurology diagnostic and monitoring devices market going forward. Neurodegenerative diseases refer to a group of disorders characterized by the progressive degeneration or death of nerve cells (neurons) in the brain and/or spinal cord. Neurodegenerative diseases are growing due to aging populations, increased life expectancy, and greater exposure to environmental and genetic risk factors. Neurology diagnostic and monitoring devices help in neurodegenerative diseases by providing precise and real-time assessment of brain function and disease progression, enabling early diagnosis, tailored treatment plans, and effective monitoring of therapeutic responses. For instance, in April 2025, according to the Alzheimer's Association, a US-based non-profit organization, more than 7 million Americans currently live with Alzheimer's, and this number is expected to increase to nearly 13 million by 2050. Therefore, the increasing prevalence of neurodegenerative diseases is driving the growth of the neurology diagnostic and monitoring devices industry.

Key Players In The Global Neurology Diagnostic And Monitoring Devices Market

Major companies operating in the neurology diagnostic and monitoring devices market are Siemens Healthineers, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Shimadzu Corporation, Masimo Corporation, Nihon Kohden Corporation, Elekta AB, Natus Medical Incorporated, Esaote S.p.A., Zynex Medical Inc., Canon Medical Systems Corporation, Neurosoft S.A., Cadwell Industries Inc., Cogito Brains Inc., Blackrock Neurotech Inc., Compumedics Limited, Ceribell Inc., Nexstim Plc, NeuroMetrix Inc., Lumos Labs Inc., Soterix Medical Inc., Advanced Brain Monitoring Inc., Sense Neuro Diagnostics Inc.

Global Neurology Diagnostic And Monitoring Devices Market Trends and Insights

Major companies operating in the neurology diagnostic and monitoring devices market are focusing on developing advanced solutions, such as an image-guided therapy system, to enhance precision in neurovascular procedures. An image-guided therapy system refers to a medical technology used to assist in the planning, navigation, and execution of various therapeutic procedures, often in real-time. For instance, in February 2024, Koninklijke Philips N.V., the Netherlands-based health technology company, launched the new Azurion neuro biplane system to accelerate and enhance the minimally invasive diagnosis and treatment of neurovascular patients. It offers unique features such as enhanced C-arm rotation and angulation for improved imaging flexibility, rapid transitioning between 2D and 3D imaging for optimized workflow, comprehensive table-side control to maintain a sterile field, automatic beam rotation for accurate image orientation, a new head immobilizer to support stroke patient care, and integration of AI and machine learning to monitor performance and predict service issues.

What Are Latest Mergers And Acquisitions In The Neurology Diagnostic And Monitoring Devices Market?

In January 2024, Aditxt, Inc., a US-based healthcare company, acquired proprietary EEG monitoring technologies—including NeuroCap and NeuroEEG—from Brain Scientific, Inc. for an undisclosed amount. With this acquisition, Aditxt aimed to expand into the neurology diagnostics and monitoring space by integrating telehealth-enabled EEG systems that can streamline testing and interpretation for remote and critical-care settings. Brain Scientific is a US-based company that provides neurology diagnostic and monitoring devices.

Regional Outlook

North America was the largest region in the neurology diagnostic and monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Neurology Diagnostic And Monitoring Devices Market?

The neurology diagnostic and monitoring devices market consists of sales of electromyography (EMG) systems, magnetoencephalography (MEG) systems, functional magnetic resonance imaging (fMRI) systems, and transcranial magnetic stimulation (TMS) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.